Harvard Bioscience, Inc. (HBIO) Revenue History
Harvard Bioscience, Inc. (HBIO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $104.52M |
| 2017-12-31 | $77.41M |
| 2018-12-31 | $120.77M |
| 2019-12-31 | $116.18M |
| 2020-12-31 | $102.10M |
| 2021-12-31 | $118.90M |
| 2022-12-31 | $113.33M |
| 2023-12-31 | $112.25M |
| 2024-12-31 | $94.14M |
| 2025-12-31 | $86.55M |
How HBIO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ETON | Eton Pharmaceuticals Inc. | $79.95M |
| RMTI | Rockwell Medical Inc. | $69.26M |
| NTLA | Intellia Therapeutics Inc. | $67.67M |
| KURA | Kura Oncology Inc. | $67.48M |
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
These are five companies in the same sector as HBIO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Harvard Bioscience, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("HBIO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HBIO | $7.90 | +3.27% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |